Trial NCT04152863

View at ClinicalTrials.gov 
Org. Study IDs: V937-011
Secondary IDs: 2019-002034-36

Last trial update was posted on 2024-03-04

MeSH Interventions

Pembrolizumab

MeSH Conditions

Melanoma

Other Conditions

Advanced/Metastatic Melanoma

Stopping Reasons

Business Reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID